SCHEMBL5407858

SCHEMBL5407858

Oc1ccccc1C(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TDP1 Q9NUW8 3/20 0.52
TSHR P16473 2/20 0.52
LMNA P02545 5/20 0.43
CA2 P00918 5/20 0.43
ALOX15 P16050 3/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 2/20 0.43
EGFR P00533 2/20 0.43
FYN P06241 2/20 0.43
MMP9 P14780 2/20 0.43
HPGD P15428 2/20 0.43
CA4 P22748 2/20 0.43
RECQL P46063 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CA5A P35218 2/20 0.43
CA12 O43570 1/20 0.43
GMNN O75496 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8662461 0.89 ALDH1A1 (0.46) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL8607372 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL29563390 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL2096276 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL584399 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL23202728 0.79 ALDH1A1 (0.56) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL29492110 0.79 ALDH1A1 (0.56) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL69460 0.79 ALDH1A1 (0.56) ALDH1A1TDP1TSHRLMNACA2
SCHEMBL1873962 0.78 ALDH1A1 (0.50) ALDH1A1TDP1TSHRLMNACA2
Ammonia Solution, Strong SCHEMBL28699487 0.77 ALDH1A1 (0.54) ALDH1A1TDP1TSHRLMNACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169955-B2 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2007-01-30 US disclosed
US-20050113567-A1 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2005-05-26 US disclosed
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE NIHON NOHYAKU CO., LTD. (JP) 2003-10-02 US disclosed
EP-1253128-A1 PERFLUOROISOPROPYLBENZENE DERIVATIVES Nihon Nohyaku Co., Ltd. (JP) 2002-10-30 EP disclosed
US-5266668-A Substituted phenyl α-fluoroacrylates HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-30 US disclosed
EP-0249867-B1 SUBSTITUTED PHENYL ESTERS OF ALPHA-FLUOROACRYLIC ACID HOECHST AKTIENGESELLSCHAFT (DE) 1992-01-02 EP disclosed
EP-0249867-A2 Substituted phenyl esters of alpha-fluoroacrylic acid HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE AFF1, CBR1, RER1 ALDH1A1 1079/4885TDP1 1436/4885TSHR 232/4885
US-20050113567-A1 Perfluoroisopropylbenzene derivative FFAR3, CBR3, HCAR3 ALDH1A1 2953/4885TDP1 3877/4885TSHR 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.